Kallisio advances precision cancer care through patient-specific platforms that combine design automation, rapid 3D manufacturing, and seamless clinical workflows. Its flagship Stentra™ solution, FDA-cleared and CE-marked, improves radiotherapy accuracy for head and neck cancer patients and has been recognized as Best New Radiology Technology Solution at the 2026 MedTech Breakthrough Awards.
With over 30 years in medical device innovation across diagnostics, critical care, and drug delivery, Rajan Patel brings the perspective of a company that has navigated the full journey from concept to cleared device to clinical-scale deployment.